Perspective

• Medscape 2050: Bronwyn Williams   Bronwyn Williams, futurist, economist, business trend analyst, and partner at Flux Trends, discusses the future of healthcare economics and the “return on investment on life.”
  Medscape, March 25, 2025
• Critical Data on Breast Cancer Rates and Mortality   Dr Maurie Markman discusses key data from the American Cancer Society’s biennial analysis on breast cancer statistics.
  Medscape Oncology, March 25, 2025
• ACC 2025 Mandrola’s 5 Picks for ACC 25 Trials on cerebral protection in TAVR, fluid restriction in heart failure, and risk factor management in AF are among John Mandrola’s picks from the upcoming ACC Scientific Sessions.
  theheart.org on Medscape, March 25, 2025
• Stop Falling Into These Medical School Study Traps   Dr JR Smith discusses common mistakes medical students make while studying.
  Medscape, March 25, 2025
• When to Invite a Third Person Into the Room When should the patient-clinician dyad become a triad? A resident neurologist ponders the question in the context of the aging patient population.
  Medscape Neurology, March 25, 2025
• Easing Patients Beyond Panic in Metastatic Breast Cancer   Dr Erica Mayer of Dana-Farber Cancer Institute and a patient with metastatic breast cancer discuss how oncologists can ease patients beyond panic after a diagnosis of metastatic breast cancer.
  Medscape, March 25, 2025
• When a Cancer Drug Shortens Life: Lessons From ARIEL4 Dr Gyawali unpacks the ARIEL4 trial, in which a cancer drug shortened survival by 6 months. What went wrong, and what can we learn to prevent future harm?
  Medscape Oncology, March 25, 2025
• Improving Cognitive Outcomes in Multiple Sclerosis   Drs Frederick Foley and John DeLuca share clinical insights for the assessment and treatment of cognitive dysfunction in multiple sclerosis.
  Consortium of Multiple Sclerosis Centers, March 25, 2025
• Conference MDAngle: AAN 2025 Myasthenia Gravis Dr Nicholas Silvestri shares AAN 2025 highlights, including anticipated presentations, quick takeaways, and insights on the impact of new myasthenia gravis research.
  Medscape, March 25, 2025
• AAN 2025: Anticipating New Approaches in Myasthenia Gravis   Dr Nicholas Silvestri looks ahead to new data on existing agents and emerging therapies for myasthenia gravis.
  Medscape, March 25, 2025
• US Falls Behind Other Countries in Avoidable Deaths   It just doesn’t work to keep throwing money at poor health outcomes.
  Medscape, March 25, 2025
• S3 Episode 3: The 2025 updates of the American Diabetes Association   Drs Carol H. Wysham and Rozalina G. McCoy discuss the 2025 updates of the American Diabetes Association, including comorbidities, dental care, sexual dysfunction, and CGM use.
  Medscape, March 25, 2025
• HCP Perspective on Managing CML Patients Discussion of HCP Perspectives on managing CML patients with BCR::ABL1 TKIs.
  Medscape Medical Affairs, March 25, 2025
• Acute Arthritis in Traveller Reveals Rare Viral Infection
  Medscape News UK, March 25, 2025
• Jha: It’s Time to Update Our 1950-Style Healthcare Delivery   A physician from 1950 would recognize the structure and financing of our healthcare system, Jha says. That’s nonsensical, and we now have the technology to change it.
  Medscape, March 24, 2025
• Jha: Government Must Prep for ‘Inevitable’ Future Pandemics   More outbreaks, pandemics, and biothreats are coming, says Ashish K. Jha. But these crises don’t have to kill millions or cripple society if governments invest in preparedness.
  Medscape, March 24, 2025
• Multivitamins Slow Biological Aging in a Large Trial   Dr JoAnn Manson discusses recent data on the use of multivitamin supplementation to slow aging, presented at the American Heart Association’s EPI/Lifestyle 2025 Scientific Sessions.
  Medscape Ob/Gyn, March 24, 2025
• Williams: Rich/Poor Healthcare Inequity Is ‘Mind-Boggling’   From children stunted by malnutrition to billionaires experimenting with longevity, Bronwyn Williams says the global healthcare divide has reached staggering proportions.
  Medscape, March 24, 2025
• Foot Surgery, a Pulmonary Embolism, and a Negligence Claim The Medical Protection Society says lessons can be learned from the case of a patient given an incorrect risk score for pulmonary embolism and what followed.
  Medical Protection Society, March 24, 2025
• C3 Glomerulopathy: Diagnosing a Rare and Variable Disease   Nonspecific signs on a medical exam may point to C3 glomerulopathy, a rare disease with a variable course ranging from quiescence to rapidly progressive kidney failure, reports Dr Fernando Fervenza.
  Medscape, March 24, 2025